Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Safety Administration All age groups Haemophilus influenzae type B
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Administration Newborn (0-1 years) Adults (18+) Tuberculosis Typhoid Hepatitis B Diphtheria Tetanus Poliomyelitis Influenza Pertussis
Efficacy/effectiveness Administration Newborn (0-1 years) Children (2-9 years) Tuberculosis Diphtheria Tetanus Pertussis Measles
Economic aspects Newborn (0-1 years) Children (2-9 years) Haemophilus influenzae type B
Economic aspects Newborn (0-1 years) Children (2-9 years) Haemophilus influenzae type B
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus